ELIGIBILITY for Pharmaceutical Benefits Scheme (PBS) access to COVID-19 oral antiviral treatments, has been widened from today.
Under the new criteria, First Nations people aged 30 years and older with one risk factor, rather than two, can now access Lagevrio or Paxlovid through the PBS.
THE Pharmaceutical Society of Australia (PSA) National Board has elected Professor Mark Naunton as President Elect at its Dec 2025 board meeting.
THE Pharmaceutical Society of Australia (PSA) Foundation has announced the launch of the Hugh and Mary Darragh Postgraduate Scholarship, with expressions of interest now formally open.
THE Public Health Association of Australia (PHAA) has launched a campaign to save VicHealth after the Victorian Government announced it will effectively shut down the world’s first health promotion foundation and place its preventative health functions within the Health Department.